Rheumatoid Arthritis

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres | March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Link between Autoimmunity and Environmental Exposure Needs Further Research

Vanessa Caceres | March 8, 2012

Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Carrie Printz | February 28, 2012

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).

A Patient’s Perspective on RA

Lisa C. Glavish | February 3, 2012

I was diagnosed in April 2010, at 44 years old, with seropositive RA; the disease rapidly turned my life upside down.

Letter: RA Approval for IL-1Ra

William Arend, MD | February 3, 2012

Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.

A Short History of Rheumatoid Arthritis Therapeutics

Simon M. Helfgott, MD | January 13, 2012

Or, why I chose to become a rheumatologist

Give Rheumatology Patients a Helping Hand

Staff | January 13, 2012

Nearly 10 million Americans suffer from carpal tunnel syndrome, a condition that disables a key nerve in the wrist resulting in numbness, tingling, weakness, and loss of function in the hands and wrist. These symptoms are similar to those of rheumatoid arthritis and other rheumatic conditions, and it is important that patients know the difference.